Author:
Anjani Gummadi,Rawat Amit
Reference26 articles.
1. Yang X, Zhang C, Chen G, Sun C, Li J (2019) Antibodies: the major participants in maternal-fetal interaction. J Obstet Gynaecol Res 45(1):39–46
2. Panaitescu AM, Nicolaides K (2018) Maternal autoimmune disorders and fetal defects. J Matern-Fetal Neonatal Med 31(13):1798–1806
3. Sakthiswary R, Rajalingam S, Norazman MR, Hussein H (2015) Antinuclear antibodies predict a higher number of pregnancy loss in unexplained recurrent pregnancy loss. Clin Ter 166(2):e98–e101
4. Hefler-Frischmuth K, Walch K, Hefler L, Tempfer C, Grimm C (2017) Serologic markers of autoimmunity in women with recurrent pregnancy loss. Am J Reprod Immunol 77(4).
https://doi.org/10.1111/aji.12635
5. Ticconi C, Pietropolli A, Borelli B, Bruno V, Piccione E, Bernardini S et al (2016) Antinuclear autoantibodies and pregnancy outcome in women with unexplained recurrent miscarriage. Am J Reprod Immunol 76(5):396–399